BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9892109)

  • 1. Somatic genetic alterations in BRCA2-associated and sporadic male breast cancer.
    Tirkkonen M; Kainu T; Loman N; Jóhannsson OT; Olsson H; Barkardóttir RB; Kallioniemi OP; Borg A
    Genes Chromosomes Cancer; 1999 Jan; 24(1):56-61. PubMed ID: 9892109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations.
    Tirkkonen M; Johannsson O; Agnarsson BA; Olsson H; Ingvarsson S; Karhu R; Tanner M; Isola J; Barkardottir RB; Borg A; Kallioniemi OP
    Cancer Res; 1997 Apr; 57(7):1222-7. PubMed ID: 9102202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosome 8p alterations in sporadic and BRCA2 999del5 linked breast cancer.
    Sigbjörnsdottir BI; Ragnarsson G; Agnarsson BA; Huiping C; Barkardottir RB; Egilsson V; Ingvarsson S
    J Med Genet; 2000 May; 37(5):342-7. PubMed ID: 10807692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium.
    Lancet; 1997 May; 349(9064):1505-10. PubMed ID: 9167459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High incidence of loss of heterozygosity in breast tumors from carriers of the BRCA2 999del5 mutation.
    Ingvarsson S; Geirsdottir EK; Johannesdottir G; Sigbjörnsdóttir BI; Eiriksdottir G; Ragnarsson G; Agnarsson BA; Gudmundsson J; Jonasson JG; Sigurdsson A; Egilsson V; Barkardottir RB
    Cancer Res; 1998 Oct; 58(19):4421-5. PubMed ID: 9766673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of genomic abnormalities between BRCAX and sporadic breast cancers studied by comparative genomic hybridization.
    Gronwald J; Jauch A; Cybulski C; Schoell B; Böhm-Steuer B; Lener M; Grabowska E; Górski B; Jakubowska A; Domagała W; Chosia M; Scott RJ; Lubiński J
    Int J Cancer; 2005 Mar; 114(2):230-6. PubMed ID: 15540206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of BRCA2-association in hereditary breast carcinomas using array-CGH.
    Joosse SA; Brandwijk KI; Devilee P; Wesseling J; Hogervorst FB; Verhoef S; Nederlof PM
    Breast Cancer Res Treat; 2012 Apr; 132(2):379-89. PubMed ID: 20614180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple copies of mutant BRCA1 and BRCA2 alleles in breast tumors from germ-line mutation carriers.
    Staff S; Nupponen NN; Borg A; Isola JJ; Tanner MM
    Genes Chromosomes Cancer; 2000 Aug; 28(4):432-42. PubMed ID: 10862052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative genomic hybridization analysis on male breast cancer.
    Rudlowski C; Schulten HJ; Golas MM; Sander B; Barwing R; Palandt JE; Schlehe B; Lindenfelser R; Moll R; Liersch T; Schumpelick V; Gunawan B; Füzesi L
    Int J Cancer; 2006 May; 118(10):2455-60. PubMed ID: 16353155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinico-pathological characteristics of BRCA1- and BRCA2-related breast cancer.
    Chappuis PO; Nethercot V; Foulkes WD
    Semin Surg Oncol; 2000 Jun; 18(4):287-95. PubMed ID: 10805950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A population study of mutations and LOH at breast cancer gene loci in tumours from sister pairs: two recurrent mutations seem to account for all BRCA1/BRCA2 linked breast cancer in Iceland.
    Arason A; Jonasdottir A; Barkardottir RB; Bergthorsson JT; Teare MD; Easton DF; Egilsson V
    J Med Genet; 1998 Jun; 35(6):446-9. PubMed ID: 9643283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double heterozygosity for mutations in the BRCA1 and BRCA2 genes in a breast cancer patient.
    Tsongalis GJ; Linfert DR; Johnson RC; Ackroyd R; Berman MM; Ricci A
    Arch Pathol Lab Med; 1998 Jun; 122(6):548-50. PubMed ID: 9625424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatic mutations in the BRCA2 gene and high frequency of allelic loss of BRCA2 in sporadic male breast cancer.
    Kwiatkowska E; Teresiak M; Breborowicz D; Mackiewicz A
    Int J Cancer; 2002 Apr; 98(6):943-5. PubMed ID: 11948477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRCA2 germline mutations in male breast cancer cases and breast cancer families.
    Couch FJ; Farid LM; DeShano ML; Tavtigian SV; Calzone K; Campeau L; Peng Y; Bogden B; Chen Q; Neuhausen S; Shattuck-Eidens D; Godwin AK; Daly M; Radford DM; Sedlacek S; Rommens J; Simard J; Garber J; Merajver S; Weber BL
    Nat Genet; 1996 May; 13(1):123-5. PubMed ID: 8673091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct molecular pathogeneses of early-onset breast cancers in BRCA1 and BRCA2 mutation carriers: a population-based study.
    Armes JE; Trute L; White D; Southey MC; Hammet F; Tesoriero A; Hutchins AM; Dite GS; McCredie MR; Giles GG; Hopper JL; Venter DJ
    Cancer Res; 1999 Apr; 59(8):2011-7. PubMed ID: 10213514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency of BRCA1 and BRCA2 germline mutations in Japanese breast cancer families.
    Ikeda N; Miyoshi Y; Yoneda K; Shiba E; Sekihara Y; Kinoshita M; Noguchi S
    Int J Cancer; 2001 Jan; 91(1):83-8. PubMed ID: 11149425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BRCA2 mutations in primary breast and ovarian cancers.
    Lancaster JM; Wooster R; Mangion J; Phelan CM; Cochran C; Gumbs C; Seal S; Barfoot R; Collins N; Bignell G; Patel S; Hamoudi R; Larsson C; Wiseman RW; Berchuck A; Iglehart JD; Marks JR; Ashworth A; Stratton MR; Futreal PA
    Nat Genet; 1996 Jun; 13(2):238-40. PubMed ID: 8640235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct genomic profiles in hereditary breast tumors identified by array-based comparative genomic hybridization.
    Jönsson G; Naylor TL; Vallon-Christersson J; Staaf J; Huang J; Ward MR; Greshock JD; Luts L; Olsson H; Rahman N; Stratton M; Ringnér M; Borg A; Weber BL
    Cancer Res; 2005 Sep; 65(17):7612-21. PubMed ID: 16140926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of methylation of CpG dinucleotides within the promoter of the breast cancer susceptibility gene BRCA2 in normal tissues and in breast and ovarian cancers.
    Collins N; Wooster R; Stratton MR
    Br J Cancer; 1997; 76(9):1150-6. PubMed ID: 9365162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Constitutional genomic instability with inversions, duplications, and amplifications in 9p23-24 in BRCA2 mutation carriers.
    Savelyeva L; Claas A; Matzner I; Schlag P; Hofmann W; Scherneck S; Weber B; Schwab M
    Cancer Res; 2001 Jul; 61(13):5179-85. PubMed ID: 11431357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.